CRISPR dispute likely to continue in federal courts


Following the CRISPR/Cas9 patent hearing on December 6 between The Broad Institute and University of California, Berkeley (UCB), it is very unlikely that the case will end at the US Patent and Trademark Office (USPTO), according to one lawyer.

CRISPR, CRISPR/Cas9, The Broad Institute, University of California, patent